The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease: Meta-analysis: rifaximin therapy in uncomplicated diverticular disease
Open accessAbstract
BACKGROUND: Diverticular disease of the colon is a common gastrointestinal disease. Although most patients remain asymptomatic for their whole life, about 20-25% present symptoms related to 'diverticular disease'. Several randomised trials verified efficacy of a poorly absorbed antibiotic, such as rifaximin-α (rifaximin), in soothing symptoms and preventing diverticulitis. AIM: To evaluate the long-term efficacy administration of rifaximin plus fibre supplementation vs. fibre supplementation alone, on symptoms and complications, in patient with symptomatic uncomplicated diverticular disease. METHODS: Pertinent studies were selected from the Medline, and the Cochrane Library Databases, references from published articles and reviews. Conventional meta-analysis according to DerSimonian and Laird method was used for the pooling of the results. The outcomes were 1- year complete symptom relief, and 1- year complication incidence. The rate difference (RD, with 95% CI) and the Number Needed to Treat (NNT) were used as measure of the therapeutic effect on each outcome. RESULTS: Four prospective randomised trials including 1660 patients were selected. The pooled RD for symptom relief was 29.0% (rifaximin vs. control; 95% CI 24.5-33.6%; P<0.0001; NNT=3). The pooled RD for complication rate was -1.7% in favour of rifaximin (95% CI -3.2 to -0.1%; P=0.03; NNT=59). When considering only acute diverticulitis, the pooled RD in the treatment group was -2% (95% CI -3.4 to -0.6%; P=0.0057; NNT=50). CONCLUSIONS: In symptomatic uncomplicated diverticular disease, treatment with rifaximin plus fibre supplementation is effective in obtaining symptom relief and preventing complications at 1 year.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267 · cited 1×
“heterogeneity, a visual display was obtained, representing the results on the L’Abbé plot.(36)”
Method
Cited by
Hall, J., Hardiman, K., Lee, S., Lightner, A., Stocchi, L., Paquette, I. M., Steele, S. R., Feingold, D. L., & Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons (2020) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001679 · Cited by 485
Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights
Strate, L. L., Modi, R., Cohen, E., & Spiegel, B. M. R. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.194 · Cited by 367
Gastrointestinal Tract Disorders in Older Age
Dumic, I., Nordin, T., Jecmenica, M., Stojkovic Lalosevic, M., Milosavljevic, T., & Milovanovic, T. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/6757524 · Cited by 314
Metadata
- Authors
- Bianchi, M., Festa, V., Moretti, A., Ciaco, A., Mangone, M., Tornatore, V., Dezi, A., Luchetti, R., De Pascalis, B., Papi, C., & Koch, M.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2011-03-02
- Volume
- 33
- Issue
- 8
- Pages
- 902-910
- ISSN
- 0269-2813 (ISSN-L)
- OpenAlex
- W1557515811
- Cited by
- 164
- References
- 2
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease: Meta-analysis: rifaximin therapy in uncomplicated diverticular disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2011.04606.x
- The paper
- Bianchi, M., Festa, V., Moretti, A., Ciaco, A., Mangone, M., Tornatore, V., Dezi, A., Luchetti, R., De Pascalis, B., Papi, C., & Koch, M. (2011). Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease: Meta-analysis: rifaximin therapy in uncomplicated diverticular disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2011.04606.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.